US 9359313
Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator
granted A61KA61K31/155A61K31/426
Quick answer
US patent 9359313 (Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator) held by VTV THERAPEUTICS LLC expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VTV THERAPEUTICS LLC
- Grant date
- Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/155, A61K31/426, A61P, A61P3/00